Stepahne Altaba, Camille Chypre, and Anne Jacquet
Genomic Vision has expanded its senior management team by appointing Stephane Altaba as vice-president of corporate development, Camille Chypre as vice-president of research and development, and Anne Jacquet as medical director. Altaba previously served as vice-president of corporate business development at Nordic Pharma Group. Prior to that, he was director of corporate licenses at Sanofi. Chypre comes to Genomic Vision after serving as executive vice president at LXRepair. Jacquet has worked in preclinical and clinical research in the field of cardiovascular disease and oncology, prior to joining Genomic Vision.